精准运动用于早期阿尔茨海默病老年人:FIT-AD序贯多重分配随机试验(SMART)研究方案
该II期序贯多重分配随机试验(SMART)将在108对参与者及其研究伙伴中,检验基于有氧适能应答定制的6个月有氧运动对早期症状性阿尔茨海默病(AD)患者的有氧适能、白质高信号体积(WMHv)及患者中心结局的效果与机制,并比较高强度间歇训练(HIIT)与有氧联合抗阻运动(CARE)对无应答者的改善作用。
要点
- 试验纳入108对参与者及其研究伙伴,按2:1随机分配至3个月中等强度持续训练(MICT)或6个月拉伸对照。
- MICT后以峰值摄氧量(VO2peak)增幅<5%定义无应答者,再按1:1随机分配至HIIT或CARE继续3个月。
- 主要结局为0、3、6、9、12个月的VO2peak及0、6、12个月的WMHv。
核心结论
- 该试验将检验基于有氧适能应答定制的有氧运动对早期症状性AD老年人的效果与机制。
- 作者认为,精准运动对推进AD运动研究至关重要。
研究设计与样本
- 该II期试验为序贯多重分配随机试验(SMART),计划纳入108对参与者及其研究伙伴。
- 参与者按2:1分配至3个月MICT或6个月拉伸对照。
- MICT组3个月后以VO2peak增幅<5%定义无应答者,按1:1再随机分配至HIIT或CARE继续3个月;应答者继续MICT。
- 所有参与者在干预后再随访6个月。
主要发现
- 原文报告该试验有80%把握度,假设6个月和12个月脱落率分别为18%和25%,以检测有氧适能变化。
- 原文提及既往在AD/ADRD老年人中报告过VO2peak应答的个体差异,但该差异如何影响运动干预应答尚不清楚。
关键数值与推荐
- 无应答定义为MICT后VO2peak增幅<5%。
- 主要结局为0、3、6、9、12个月测量的VO2peak及0、6、12个月测量的WMHv。
- 次要结局包括记忆、躯体功能、痴呆行为和心理症状(BPSD)、生活质量(QoL)、照护者负担及AD血浆生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aerobic exercise is promising for preventing Alzheimer's disease (AD) and AD-related dementia (ADRD), but exercise trials have shown mixed results. An important, understudied factor potentially contributing to mixed results is individual differences in aerobic fitness responses to moderate-intensity continuous training (MICT). This trial will test the effects and mechanisms of 6 months of aerobic exercise tailored on aerobic fitness response to MICT in community-dwelling older adults with early symptomatic AD. We aim to (I) test the effects of aerobic exercise on aerobic fitness, white matter hyperintensity volume (WMHv), and patient-centered outcomes in older adults with early symptomatic AD; (II) determine the best exercise to improve aerobic fitness and reduce non-responses over 6 months; and (III) examine the mechanisms of aerobic exercise's action on cognition. METHODS: This stage II trial is a Sequential, Multiple Assignment, Randomized Trial (SMART). The hypothesis is that MICT augmented with high-intensity interval training (HIIT) or combined aerobic and resistance exercise (CARE) will improve aerobic fitness, WMHv, and AD/ADRD plasma biomarkers. This trial will enroll 108 dyads (participants and their study partners). Participants (n = 108) are randomized using a 2:1 allocation ratio to 3-month MICT or 6-month stretching control. After the initial 3-month intervention period for participants assigned to MICT, aerobic fitness is measured with peak oxygen consumption (VO2peak) from a cycle-ergometer exercise testing and the shuttle walk test to identify non-response (< 5% increase). Non-responders are subsequently re-randomized (1:1) to either HIIT or CARE for 3 months. Responders continue MICT. All participants are followed for an additional 6 months post-intervention. Primary outcomes are VO2peak measured at 0, 3, 6, 9, and 12 months and WMHv at 0, 6, and 12 months. Secondary outcomes include memory, physical function, behavioral and psychological symptoms of dementia (BPSD), quality of life (QoL), caregiver burden, and AD plasma biomarkers. This trial has 80% power, assuming 18% and 25% attrition at 6 and 12 months, respectively, to detect changes in aerobic fitness. DISCUSSION: Individual differences in VO2peak responses were reported in older adults with AD/ADRD previously but how this affects response to exercise interventions is unknown, Precision exercise tailored to VO2peak is critical to advance exercise research in AD. TRIAL REGISTRATION: ClinicalTrials.gov NCT05877196. Registered on May 25, 2023.
引用
- Yu F, Todd M, Salisbury D, et al. Precision exercise in older adults with early Alzheimer's disease: The study protocol of the FIT-AD Sequential, Multiple Assignment, Randomized Trial (SMART). Trials. 2025. PMID: 41094623. doi:10.1186/s13063-025-09040-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。